CIK 0001846253
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- 4 Shares withheld for taxes Director gave up 83,717 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 115,000 shares at $4.52 ($519,800)
- 4 Open-market sale Director sold 9,000 shares at $4.05 ($36,450)
- 4 Open-market sale Director sold 1,000 shares at $4.05 ($4,050)
- 4 Open-market sale Director sold 50,000 shares at $3.89 ($194,500)
- 4 Open-market buy Chief Executive Officer bought 440,000 shares at $3.40 ($1,496,000)
- 4 Grant or award Executive VP, Finance & CFO acquired 40,625 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 109,375 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 40,625 shares (grant or award)
- 4 Shares withheld for taxes EVP, Finance and CFO gave up 8,042 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 9,543 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 17,086 shares (to pay taxes)
- 4 Grant or award Director acquired 8,753 shares (grant or award)
- 4 Grant or award Director acquired 39,517 shares (grant or award)
- 4 Grant or award Director acquired 17,506 shares (grant or award)
- 4 Grant or award Director acquired 8,753 shares (grant or award)
Page 6 of 9 · 174 filings